Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 42.43%903.76M | 38.15%518.76M | 59.42%205.38M | 7.03%908.29M | -1.48%634.53M | -4.55%375.5M | -17.56%128.83M | 22.12%848.61M | 48.88%644.09M | 32.29%393.39M |
| Refunds of taxes and levies | ---- | ---- | ---- | 283.23%953.36K | 201.53%750.12K | 201.53%750.12K | ---- | -87.87%248.77K | 729.08%248.77K | 2,978.63%248.77K |
| Cash received relating to other operating activities | 138.88%117.42M | 131.59%58.74M | -6.87%15.57M | -81.95%55.49M | -76.85%49.15M | -86.53%25.36M | -41.33%16.72M | 184.98%307.51M | 543.00%212.28M | 625.77%188.31M |
| Cash inflows from operating activities | 49.20%1.02B | 43.79%577.5M | 51.81%220.95M | -16.57%964.73M | -20.10%684.43M | -30.99%401.62M | -21.23%145.55M | 43.67%1.16B | 83.95%856.62M | 79.99%581.94M |
| Goods services cash paid | 42.63%326.49M | 38.18%194.89M | 56.50%80.29M | -14.95%331.84M | -24.53%228.91M | -39.42%141.04M | -46.43%51.3M | -35.10%390.19M | -35.52%303.32M | -30.17%232.83M |
| Staff behalf paid | 39.22%147.42M | 39.10%97.45M | 34.50%52.25M | 49.51%145.81M | 42.06%105.89M | 55.94%70.06M | 67.96%38.84M | 71.09%97.53M | 262.09%74.54M | 216.02%44.93M |
| All taxes paid | 20.22%53.7M | 19.93%37.16M | 38.38%17.19M | 3.00%72.53M | -14.29%44.67M | -4.88%30.99M | 32.88%12.43M | 107.25%70.41M | 464.40%52.12M | 297.14%32.58M |
| Cash paid relating to other operating activities | 20.97%164.89M | -9.15%93.18M | -32.49%46.94M | -37.05%178.26M | -44.46%136.31M | -13.52%102.56M | 106.70%69.53M | 122.19%283.16M | 599.23%245.41M | 351.78%118.59M |
| Cash outflows from operating activities | 34.26%692.5M | 22.64%422.69M | 14.28%196.67M | -13.41%728.44M | -23.63%515.78M | -19.65%344.65M | 6.31%172.1M | 2.64%841.29M | 26.17%675.39M | 12.25%428.92M |
| Net cash flows from operating activities | 94.89%328.68M | 171.77%154.81M | 191.42%24.28M | -25.00%236.29M | -6.94%168.65M | -62.77%56.96M | -216.05%-26.56M | 2,230.55%315.07M | 360.28%181.22M | 360.36%153.02M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 4,590.08%59.71M | --59.71M | --45.25K | -99.67%3.22M | -99.87%1.27M | ---- | ---- | 22.39%981.01M | 97,986.79%980.87M | 12,671.70%510.87M |
| Cash received from returns on investments | -58.18%88.24K | ---- | ---- | -98.26%210.97K | -98.28%210.97K | -99.72%34.5K | ---- | -77.28%12.12M | 279.72%12.26M | 43,675.83%12.26M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -87.42%68.56K | -89.56%56.48K | --54.94K | 468.96%550.2K | 614.37%545.16K | 786.02%540.81K | ---- | -99.17%96.7K | --76.31K | --61.04K |
| Cash received relating to other investing activities | ---- | ---- | ---- | --2.88M | --2.88M | --2.88M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 1,119.11%59.87M | 1,628.96%59.77M | --100.2K | -99.31%6.87M | -99.51%4.91M | -99.34%3.46M | ---- | -22.35%993.22M | 180.38%993.2M | 868.36%523.19M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -34.66%190M | 9.22%78.82M | 9.60%31.41M | 279.44%457.94M | 820.05%290.77M | 371.29%72.17M | 159.36%28.66M | 246.19%120.69M | 105,304.18%31.6M | 153,277.55%15.31M |
| Cash paid to acquire investments | -19.86%160.65M | --4.6M | --2M | ---- | -57.35%200.46M | ---- | ---- | -30.76%470M | 134,185.71%470M | --470M |
| Net cash paid to acquire subsidiaries and other business units | 544.59%130.88M | 327.89%86.88M | -73.77%5.44M | -52.62%222.28M | -95.65%20.3M | --20.3M | --20.75M | --469.11M | --466.5M | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.19%3.31M | ---- |
| Cash outflows from investing activities | -5.87%481.53M | 84.16%170.31M | -21.37%38.85M | -35.82%680.22M | -47.34%511.54M | -80.94%92.48M | 347.19%49.41M | -9.70%1.06B | 136.71%971.41M | 341.15%485.31M |
| Net cash flows from investing activities | 16.77%-421.66M | -24.17%-110.54M | 21.57%-38.75M | -911.33%-673.35M | -2,424.93%-506.63M | -335.06%-89.02M | -357.33%-49.41M | -163.18%-66.58M | 138.81%21.79M | 167.65%37.87M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -80.44%17.22M | --1.22M | ---- | 356.65%91.33M | 87,930.00%88.03M | ---- | ---- | -92.54%20M | --100K | --100K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -80.44%17.22M | --1.22M | ---- | --91.33M | --88.03M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 182.34%504.97M | 160.52%333.07M | 270.26%258.04M | 51.92%417.09M | 176.64%178.85M | 97.76%127.85M | 139.98%69.69M | 27,355.00%274.55M | 6,365.00%64.65M | 6,365.00%64.65M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --721.36K | --721.36K | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 95.14%522.19M | 161.47%334.29M | 270.26%258.04M | 72.86%509.14M | 313.28%267.6M | 97.45%127.85M | 139.98%69.69M | 9.50%294.55M | 6,375.00%64.75M | 6,375.00%64.75M |
| Borrowing repayment | 103.71%247.51M | 48.33%170.42M | 5.42%29.55M | -27.83%230.93M | -7.52%121.5M | -4.95%114.89M | 76.58%28.03M | 209.33%320M | 6,216.93%131.37M | 6,947.51%120.87M |
| Dividend interest payment | 245.63%33.7M | 301.96%26.46M | 175.83%8.95M | -37.34%17.19M | -9.07%9.75M | -9.63%6.58M | -19.97%3.24M | 71.35%27.43M | 12,764.01%10.72M | 12,017.92%7.28M |
| -Including:Cash payments for dividends or profit to minority shareholders | --10.84M | --10.84M | --1.53M | -98.95%140K | ---- | ---- | ---- | --13.39M | ---- | ---- |
| Cash payments relating to other financing activities | -90.03%12.23M | -89.55%11.41M | -97.93%1.22M | -58.83%133.04M | -59.94%122.6M | 2,572.64%109.21M | 1,418.12%58.85M | 7,594.37%323.16M | --306.02M | --4.09M |
| Cash outflows from financing activities | 15.60%293.44M | -9.71%208.29M | -55.94%39.71M | -43.16%381.16M | -43.35%253.85M | 74.44%230.69M | 278.63%90.13M | 442.30%670.59M | 20,616.75%448.12M | 7,349.39%132.24M |
| Net cash flows from financing activities | 1,562.97%228.75M | 222.52%125.99M | 1,168.25%218.33M | 134.04%127.99M | 103.59%13.76M | -52.36%-102.84M | -490.31%-20.44M | -358.73%-376.04M | -32,861.69%-383.37M | -8,606.27%-67.49M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---11.42K | ---1.36K | ---22.74K | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | 141.87%135.76M | 226.20%170.27M | 311.45%203.85M | -142.32%-309.08M | -79.77%-324.23M | -209.33%-134.92M | -656.80%-96.41M | -154.06%-127.55M | -42.08%-180.35M | 206.81%123.4M |
| Add:Begin period cash and cash equivalents | -59.86%207.27M | -59.86%207.27M | -59.86%207.27M | -19.81%516.35M | -19.81%516.35M | -19.81%516.35M | -19.81%516.35M | 62.43%643.9M | 79.39%643.9M | 79.39%643.9M |
| End period cash equivalent | 78.55%343.03M | -1.02%377.54M | -2.10%411.12M | -59.86%207.27M | -58.55%192.13M | -50.29%381.43M | -36.49%419.94M | -18.35%516.35M | 99.81%463.55M | 215.24%767.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.